News
XRPD for determining process-induced phase transformations in pharmaceutical solids Studies demonstrate utility of XRPD for determining process-induced phase transformations in pharmaceutical solids
Almelo, the Netherlands, September 2005.
Studies undertaken at the Department of Pharmaceutical Technology at the University of Bonn, using PANalytical’s X’Pert PRO MPD system, have demonstrated the value of
X-ray powder diffraction (XRPD) for detecting process-induced crystallinity changes in pharmaceutical solids.
|